Disease/Infection News

RSS

AAHIVM encourages medical providers to utilize its screening tools on National HIV Testing Day

National HIV Testing Day is June 27, 2010. Like every day in a country where there are 56,000 new HIV infections a year, approximately 150 Americans will learn of their HIV infection on June 27th. So, here's the question -- what happens on June 28th, the day after National HIV Testing Day? What do medical providers do with these newly-identified HIV patients?

25 Jun 2010

Increasing the amount of preservatives may reduce food poisoning

In response to consumer demand for more natural food, the food industry has reduced the amount of preservatives in food over recent years. A common preservative is acetic acid, which is used to stop bacterial growth in dressings, sauces, cheese and pickles.

25 Jun 2010

Researchers say ear tubes are safe for children with cochlear implants

Children who are being treated for hearing loss with cochlear implants can safely have ear tubes installed to help clear up infections, say researchers at the University of Alabama at Birmingham (UAB).

25 Jun 2010

UNICEF and Kiwanis team up to protect mothers and babies from tetanus

Kiwanis International and UNICEF have joined forces to save the lives of babies and their mothers by eliminating maternal/neonatal tetanus (MNT), a disease that kills an estimated 60,000 newborns and 30,000 mothers each year.

25 Jun 2010

MDG targets still attainable despite setbacks from global economic situation, U.N. report says

Efforts to curb poverty worldwide have been slowed by the global economic situation, but the developing world is still on track to reach the Millennium Development Goal (MDG) of halving the number of people living on less than $1 per day by 2015 - according to an annual U.N. report (.pdf) on the MDGs, which this year shows a "mixed picture" on reaching all eight targets - the Associated Press reports (Lederer, 6/23).

25 Jun 2010

Standard CRP test ineffective for detecting inflammatory bowel disease: Study

C-reactive protein (CRP) is used to assess disease activity in diverse inflammatory disorders including inflammatory bowel disease (IBD). However, in IBD, a significant number of patients present with low CRP levels despite clinically active disease.

25 Jun 2010

Editors of Canadian Medical Association Journal warn polio outbreak in Tajikistan could spread

"A large polio outbreak in Tajikistan - Europe's first in years - has the potential to further spread the dangerous virus to other regions of the world, the [editors of] the Canadian Medical Association Journal [CMAJ] warned Wednesday" in an editorial appearing in the journal, the Canadian Press reports.

25 Jun 2010

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.

24 Jun 2010

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Emergent BioSolutions Inc. announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company's international sales efforts have resulted in these sales of an undisclosed number of BioThrax doses for aggregate revenue of approximately $2.3 million in the second quarter.

24 Jun 2010

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

Last night at the 38th annual Jefferson Awards, Mark W. Kline, M.D., physician-in-chief at Texas Children's Hospital in Houston and chair of pediatrics at Baylor College of Medicine, was honored with the Jacqueline Kennedy Onassis Award for "Outstanding Community Service Benefiting Local Communities" for his dedication to treating children affected by HIV/AIDS around the world

24 Jun 2010

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.

24 Jun 2010

Patients denied insurance for bariatric surgery develop new obesity-related diseases, conditions

Patients who were denied bariatric surgery for insurance reasons developed a slew of new obesity-related diseases and conditions within three years of follow-up, according to a new study presented here at the 27th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).

24 Jun 2010

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

Telefonica Mexico and Myriad Group AG, in partnership with the Mexican Federal Ministry of Health and researchers at the Harvard School of Public Health, today announced that their combined effort in conducting a H1N1 flu survey via mobile phones was named a finalist for 'Messaging Application or Service: Social Use' at the 2010 Global Messaging Awards.

24 Jun 2010

G8 Summit needs to focus on MDGs to address AIDS crisis: IAS

In 2005 the international community made an historic commitment to achieve universal access to HIV prevention, treatment and care by 2010 at the Group of Eight (G8) summit in Gleneagles, Scotland. Despite important progress, the world is not yet on track to achieve this commitment, and there are troubling signs that donors and implementing countries are capping or shrinking funding for the HIV response.

24 Jun 2010

NIH to invest $25M over five years for international collaboration on genetic research in Africa

The NIH on Tuesday announced a partnership with Wellcome Trust and the African Society for Human Genetics that will enable African researchers to "use the latest genetic and clinical technology to study common health problems, such as cardiovascular disease, cancer and other diseases," VOA News reports (DeCapua, 6/22).

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

Through the lens of health conditions faced by people in Mbarara, Uganda, Miller-McCune examines the debate over redistributing some foreign aid funds from HIV/AIDS to fight other diseases.

24 Jun 2010

SIGA completes fourth human clinical trial of ST-246 smallpox antiviral drug candidate

SIGA Technologies, Inc., a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today the successful completion of its fourth human clinical trial, supporting the safety and tolerability of the anticipated clinical dose of ST-246®, SIGA's lead smallpox antiviral drug candidate.

23 Jun 2010

IQ Therapeutics achieves 100% survival in rabbit model at 48 hours after inhalation anthrax infection

IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.

23 Jun 2010

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.

23 Jun 2010

Disease/Infection News

AAHIVM encourages medical providers to utilize its screening tools on National HIV Testing Day

Increasing the amount of preservatives may reduce food poisoning

Researchers say ear tubes are safe for children with cochlear implants

UNICEF and Kiwanis team up to protect mothers and babies from tetanus

MDG targets still attainable despite setbacks from global economic situation, U.N. report says

Standard CRP test ineffective for detecting inflammatory bowel disease: Study

Editors of Canadian Medical Association Journal warn polio outbreak in Tajikistan could spread

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Physician-in-chief at Texas Children's Hospital honored with Jacqueline Kennedy Onassis Award

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

Patients denied insurance for bariatric surgery develop new obesity-related diseases, conditions

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

G8 Summit needs to focus on MDGs to address AIDS crisis: IAS

NIH to invest $25M over five years for international collaboration on genetic research in Africa

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Miller-McCune examines debate over redistribution of some foreign aid funds from HIV/AIDS to other diseases

SIGA completes fourth human clinical trial of ST-246 smallpox antiviral drug candidate

IQ Therapeutics achieves 100% survival in rabbit model at 48 hours after inhalation anthrax infection

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News